N/A0001488039EX-FILING FEES000148803912025-03-262025-03-2600014880392025-03-262025-03-26xbrli:purexbrli:sharesiso4217:USD

Exhibit 107

 

CALCULATION OF FILING FEE TABLE

Form S-8

Atossa Therapeutics, Inc.

Table 1 – Newly Registered Securities

Security Type

Security Class Title


 

Fee Calculation Rule

Amount Registered (1)

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Equity

Common Stock, $0.18 par value

457(a)

12,000,000

$0.725(2)

$8,700,000(2)

$153.10 per $1,000,000

$1,331.97(2)

Total Offering Amounts

12,000,000

$8,700,000

$1,331.97

Total Fee Offsets

$0

Net Fee Due

$1,331.97

(1)

In addition to the number of shares of the common stock, par value $0.18 per share (the “Common Stock”), of Atossa Therapeutics, Inc. (the “Registrant”) stated above, pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement on Form S-8 also covers any additional shares of Common Stock that become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant’s outstanding shares of Common Stock.

(2)

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and Rule 475(h) under the Securities Act, the proposed maximum offering price per share, the proposed maximum aggregate offering price and the amount of registration fee have been computed based on the average high and low prices per share of the Common Stock reported on Nasdaq on March 20, 2025.